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Quantification of interacting 
cognate odorants with olfactory 
receptors in nanovesicles
Marta Sanmartí-Espinal1,2, Patrizia Iavicoli1, Annalisa Calò1, Marta Taulés3, Roger Galve  4,5, 
M. Pilar Marco4,5 & Josep Samitier1,2,5
This study aims to improve our understanding of the interaction between olfactory receptors 
and odorants to develop highly selective biosensing devices. Natural nanovesicles (NVs) from 
Saccharomyces cerevisiae, ~100 nm in diameter, carrying either the human OR17-40 or the chimpanzee 
OR7D4 olfactory receptor (OR) tagged with the c-myc epitope at their N-terminus, are presented 
as model systems to quantify the interaction between odorant and olfactory receptors. The level 
of expression of olfactory receptors was determined at individual NVs using a novel competitive 
ELISA immunoassay comparing the values obtained against those from techniques involving the 
solubilization of cell membrane proteins and the identification of c-myc-carrying receptors. Surface 
Plasmon Resonance (SPR) measurements on L1 Biacore chips indicate that cognate odorants bind to 
their Ors, thereby quantifying the approximate number of odorants that interact with a given olfactory 
receptor. The selectivity of OR17-40-carrying NVs towards helional and OR7D4-carrying NVs towards 
androstenone has been proven in cross-check experiments with non-specific odorant molecules 
(heptanal and pentadecalactone, respectively) and in control receptors.
The animal nose is capable of distinguishing between trillions of smells at very low concentrations1,2. As a result, 
mammalian olfactory receptor-based sensing devices have shown sensitivity to a variety of odorant molecules3,4. 
Basically, the biologically active part in these devices is made up of olfactory receptors immobilized5 on func-
tionalized surfaces. Because olfactory receptors are G-coupled membrane proteins, their integration into a lipid 
envelope is considered necessary to ensure their tertiary structure and functionality is retained6. In particular, the 
isolation of natural vesicles from a cell source where mammalian olfactory receptors have been heterologously 
expressed provides an environment that is as native as possible for the receptor proteins and already proven to be 
successful in the design of the active part of bioelectronic noses7.
In order to realize practical biomolecular devices based on OR proteins embedded in natural vesicles, protein 
expression level control in vesicles as well as verification of their functionality need to be strictly managed.
In this work, we determine the expression level of two different olfactory receptors: the human OR17-40 and 
the chimpanzee OR7D4. Both are tagged with the c-myc epitope at their N-terminus in nanovesicles (NVs) from 
Saccharomyces cerevisiae. A proof of concept of the specific binding of helional by OR17-40-carrying vesicles, and 
of androstenone by OR7D4-carrying vesicles is presented, based on Surface Plasmon Resonance (SPR)8 Biacore 
T100 measurements. By comparing the Biacore signal obtained upon binding of odorant onto olfactory receptors 
to that obtained upon NVs immobilization on sensor chips, and using the number of olfactory receptors in a 
NV, we were able to estimate for the first time the approximate number of odorant molecules interacting with an 
olfactory receptor to be between 100 and 1000. Furthermore, this is a first step towards developing an array9 for 
high throughput recognition of multiple odorant10–12, which would require the use of a set of different specific 
OR-carrying NVs.
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Results
Characterization of NVs carrying olfactory receptors in solution and immobilized on the sub-
strate. Figure 1 shows a typical Cryo-EM (Fig. 1A) and a tapping-mode AFM (Fig. 1B) image of an individual 
NV in buffer solution. Suspended NVs appear as spheres with an average size of around 100 nm in Cryo-EM 
images (see Fig. 1A). When deposited onto a SHC11PEG6OCH2COOH self-assembled monolayer functionalized 
gold surface (SAM-COOH), the vesicle surface flatens, exhibiting an aspect ratio of h/w ~0.15, with h being the 
vesicle’s height and w its width, as determined by statistical analysis of the topographical profiles from AFM 
images. The SAM-COOH functionalized gold surface was taken as a reference to evaluate the shape of the NVs 
after immobilization on a hydrophilic and negatively charged surface10 such as the Biacore L1 chip (see Fig. S3). 
As expected, the surface rendered the identification impossible using conventional AFM. It is reported in the 
literature that AFM images of a dextran matrix before and after liposome (~100 nm diameter size) incubation, 
performed with conventional AFM tips, did not show any significant difference13. On SAM-COOH functional-
ized gold substrates, we achieved a maximum NV surface coverage of ~15% by controlling concentration and 
flow-time parameters in SPR devices.
The geometry of the flattened vesicles from AFM images was consistent with their size in solution which 
suggests that during the deposition process vesicle volume was preserved. In our experimental conditions, we 
found no evidence of either full vesicles collapsing or opening in combination with subsequent formation of lipid 
bilayer patches.
Assessment of the expression level of OR17-40 and OR7D4 in the total membrane fraction 
of Saccharomyces cerevisiae. Total membrane fraction of Saccharomyces cerevisiae yeast cells carrying 
heterologously expressed human c-myc-OR17-40 olfactory receptors or chimpanzee c-myc-OR7D4 olfactory 
receptors were prepared by means of cell disruption. The olfactory receptor content in the total membrane frac-
tion was determined after solubilization of all the proteins from yeast lipid membranes in fos-choline 14 (FC14) 
detergent and purification of the cmyc-ORs onto an affinity column with an anti-c-myc antibody (see Materials 
and Methods). Subsequent absorbance quantification of the eluted purified receptors gave (0.0030 ± 0.0005) g 
c-myc-OR17-40/g total proteins and (0.008 ± 0.002) g c-myc-OR7D4/g total proteins. Western blotting (WB) was 
also performed to check protein quality in these eluates. Figure 2 shows the WB of a c-myc-OR17-40 purified sam-
ple (Fig. 2A and Supplementary Figure S7A) and of a c-myc-OR7D4 purified sample (Fig. 2B and Supplementary 
Figure S7B). An immunoreactive band was observed at about 30 kDa for c-myc-OR17-40 and at about 26 kDa for 
c-myc-OR7D4, which is consistent with the molecular weight of the monomeric form of the receptors (see the 
blue arrow in Fig. 2). Bands corresponding to oligomeric forms of the receptors were also observed. The higher 
Figure 1. 2D Cryo-EM image of an individual NV carrying the OR17-40 olfactory receptor as model NV. Scale 
bar is 100 nm (A). Tapping-mode AFM image of a NV deposited onto a SAM-COOH functionalized gold chip 
(B) and its corresponding topographical profile (B, inset).
Figure 2. Western Blot of eluates of (A) purified c-myc-OR17-40 and (B) c-myc-OR7D4 after solubilization of 
the membrane fraction of Saccharomyces cerevisiae. 450 μg of c-myc-OR membrane fractions were solubilized 
using FC14 at 50 or 350 CMC.
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intensity of the monomeric OR band with 50 CMC compared to 350 CMC for the c-myc-OR17-40 eluate may be 
due to a modification of the receptor conformation that reduces accessibility of the c-myc epitope or its affinity 
or induces the masking of the c-myc epitope by the detergent. As regards the c-myc-OR7D4 eluate, neither the 50 
CMC nor the 350 CMC conditions induced any such differences.
Determination of OR expression levels in individual NVs. Because the expressed ORs of interest carry 
the c-myc peptide on their N-terminus, we built a calibration curve by ELISA immunoassay using reference pro-
teins carrying the c-myc peptide. These reference proteins were dissolved in a solution of SSTR2-carrying NVs 
as the closest negative control for OR-carrying nanovesicles. Next, the OR-carrying NV absorbance signal was 
compared against reference protein calibration curves for direct quantification of the number of receptors per NV.
Basically, reference proteins and the coating antigen are well-known proteins to which the c-myc tag peptide 
is covalently attached (c-myc-bioconjugates) achieving picomolar sensitivity in the competitive assay (see Fig. 3).
The ELISA experiment was performed at different NV concentrations (4.2·1010 to 12.6·1010 NV/mL, 25–45 μg/
mL of total protein, see Supplementary Figures S2 and S3 and Table S1).
Figure 4 shows the number of receptors per NV at each concentration obtained through direct measurements 
of the number of receptors per mL divided by the number of NV per unit volume, as determined by Nanoparticle 
Tracking Analysis (NTA). We obtained 3 ± 1 c-myc-OR17-40/NV as the weighted mean of six samples at four 
different concentrations and 6 ± 2 c-myc-OR7D4/NV as the weighted mean of four samples at four different con-
centrations. Considering the surface area of a 100 nm diameter NV, this number can be converted into a density of 
~150 ORs/µm2. This corresponds to a mean distance between receptors in the order of approximately 100 nm for 
both the OR17-40- and OR7D4- carrying NVs (see Supplementary Table S2). During the process of nanovesicle 
preparation, membrane fractions break down into nanofragments which reclose into nanovesicles. No fusion 
of nanofragments has ever been observed in previous experiments. Nanovesicle size only decreases during the 
process of sonication until a plateau is reached (personal data), and, therefore, association of upside-down frag-
ments is highly unlikely. Because of the differential composition between inner and outer lipid layers, it can be 
speculated that after sonication fragments tend to reclose following the same orientation as they originally had in 
the cell. The ELISA assay only quantifies c-myc epitopes outside the NVs, and, therefore, all ORs on the NVs are 
likely to be taken into account with this technique.
Values from direct measurements on the NVs can be compared with estimates which we obtained from the 
protein fraction of expressed OR in the lipid membrane before the actual NVs were obtained. Considering the 
molecular weight of the receptor (34 kDa), there are 5,3.1016 OR/g Total Protein. Since Figure S2C provides a 
correlation between the amount of cmyc-OR1740-nanovesicles and the amount of TP, we can estimate 19 ± 3 
ORs/NV. In the same way, for c-myc-OR7D4-nanovesicles, we calculated 0.008 g OR/g Total Protein using the 
solubilization/purification technique. Considering the molecular weight of the receptor (26 kDa), there are 
14,1.1016 OR/g Total Protein. Since Supplementary Figure S2 provides a correlation between the amount of 
cmyc-OR7D4-nanovesicles and the amount of TP, we obtained 84 ± 21 ORs/NV. Nevertheless, the quantification 
ratio between OR7D4 and OR1740 obtained using the direct nanovesicle ELISA method was 3 to 6 times lower 
than that estimated through the protein purification technique. However, this difference is relatively small con-
sidering that two very different methods were used to estimate the number of ORs/NV and could therefore be 
considered as the lowest and highest limit of OR quantification.
Assessment of OR17-40 and OR7D4 binding functionality by Surface Plasmon Resonance 
(SPR). In order to verify the binding activity of the olfactory receptors integrated in NVs towards odorants, 
we developed an SPR-based assay that uses double-reference analysis14. The experiment is described in Fig. 5 
for assessment of the OR17-40 response towards odorants. Double reference analysis was applied for measuring 
the device response to both the specific odorant helional15 (see Fig. 5B) and the control odorant heptanal (see 
Fig. 5D). NV solutions containing the OR17-40-nanovesicles or the SSTR2 control receptors-nanovesicles were 
captured in equivalent amounts (capture level ~1000 RU, see Materials and Methods) in two different channels 
of the device (Fig. 5A). Next, a solution of helional at different progressively increasing concentrations (2, 3, 
5 µM) was flowed across SPR channels (see Fig. 5B). Signals from either the SSTR2-NV (reference channel) or 
OR17-40-NV channel were first obtained by subtracting the signals provided with the running buffer (blank) 
(see Materials and Methods) from those obtained with helional. The result obtained from SSTR2-NV was then 
subtracted from that of OR17-40-NV. The same procedure was repeated for the control odorant heptanal (Fig. 5C 
and D). The two odorant solutions were flowed independently through the same chip, first through channel 1 
and 2 and then through channel 3 and 4 to avoid measurement dispersion due to heterogeneities among different 
Biacore chips.
The same procedure was performed with OR7D4-NV to assess its binding functionality against andros-
tenone16 using OR17-40-NV as control NV and pentadecalactone as control odorant.
Figure 6 shows the signal arising from the OR17-40-NV (Fig. 6A) and from the OR7D4-NV (Fig. 6B) after 
the double subtraction vs. helional and androstenone. It shows the shift of SPR dip (minimum of the SPR angle) 
registered as resonance units (RU) vs. time (sensorgram) due to the application of helional at three different 
concentrations (2, 3, 5 µM). No change in RU signal was observed when the unspecific odorant heptanal was 
applied (see the inset in Fig. 6A). Figure 6B shows the double-referenced sensorgram resulting from the appli-
cation of androstenone at three different concentrations (1, 5, 10 µM) through OR7D4 and its respective ref-
erence. Our results show that both ORs-carrying NVs responded to the corresponding specific odorant in a 
concentration-dependent manner, exhibiting selectivity towards the different odorant molecules. In OR7D4-NV, 
we found a similar behavior vs. the pentadecalactone control odorant. To verify that the choice of control NV did 
not significantly affect the SPR measurement, we also assessed the OR17-40-NV binding functionality vs. helional 
with the OR7D4-NV control (see Supplementary Fig. S6).
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It is worth noting that odorant molecule concentration in the SPR measurements was low because the device 
detected the lowest possible concentration of the odorant. Due to the odorant’s low molecular weight, SPR meas-
urements resulted in a low signal, close to the lowest detection limit of the SPR equipment. Furthermore, in 
OR7D4-NV, binding functionality assessment by SPR was also critical for high androstenone concentrations 
Figure 3. Scheme of the competitive ELISA assay. (A) Calibration curve generation using the c-myc-
Bioconjugate 1 in an SSTR2-carrying NV solution; (B) the C-myc-OR-carrying NV signal (B) is compared 
against the calibration curve performed in (A) to provide the concentration of c-myc-ORs.
www.nature.com/scientificreports/
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(>20 µM) due to the limited odorant solubility in the running buffer. This, coupled with the highly non-ideal 
behavior of the SPR response upon odorant injection, made it impossible to determine the equilibrium dissocia-
tion constant. In fact, deviations from the ideal were found in all the measurements that never reached the steady 
state during the association time (see the association part of Fig. 6A). Moreover, these SPR sensorgrams exhibited 
very slow, or no dissociation process at all, upon completion of the odorant injection (see the dissociation part of 
Fig. 6A and B).
In Fig. 7 we report the evolution of the SPR signal corresponding to the (t = 900 s) of SPR curves vs. the odor-
ant concentration. The minimum odorant concentration (LOD) that we detected with this method was 0.3 µM 
helional and 0.9 µM androstenone (see Materials and Methods) in agreement with the results reported by J.D. 
Mainland et al.17. The linear fits in Fig. 7 yielded a sensitivity of 1.8 RU/μM for helional and 0.6 RU/μM for andros-
tenone in the dose response range studied.
The corresponding linear fit for the plot of SPR signal vs. odorant concentration performed with OR17-40-NV 
using OR7D4-NV as control NVs yielded a detection limit of 0.4 µM helional and a sensitivity of 1.2 RU/μM (see 
Supporting Information, S6). This fact suggests that the choice of the control NS does not noticeably affect the 
calibration parameters of the SPR signal vs. concentration curve. The 2-3 times higher sensitivity of OR17-40-NV 
towards helional compared to that of OR7D4-NV towards androstenone could suggest a higher affinity constant 
of the OR17-40 receptor for its specific odorant, especially if we consider that other parameters affecting the SPR 
signal evolution vs. concentration (such as NV deposited mass) remained constant during the experiment.
Discussion
A good strategy to develop biomimetic sensors based on olfactory receptors consists in expressing the receptor 
proteins at the surface of natural cells used as the source for NV production. This strategy keeps the receptors 
embedded in the original membrane, i.e., a lipid bilayer with other membrane proteins or anchored proteins, 
which simulates the natural environment maintaining these proteins functional and structurally stable. However, 
the quantification of the number of receptors present in the vesicles, once prepared, and the verification of 
their ability to capture specific odorant molecules, are key issues. In this work, we have addressed these issues 
thoroughly. Using a competitive ELISA immunoassay, we determined the number of human OR17-40 and 
chimpanzee OR7D4 receptors in NVs from Saccharomyces cerevisiae yeast cells where the receptors had been 
heterologously expressed. By means of the SPR technique, we proved that the expressed receptors specifically bind 
to the helional and androstenone odorants, respectively.
For both systems, OR7D4-androstenone and OR1740-helional, the SPR signal is obtained after the subtraction 
of the blank and of the control nanovesicles signals (Fig. 8). This double-reference analysis is necessary in order 
to minimize the effect of non-specific adsorption of hydrophobic odorant molecules to the lipid component of 
liposomes, and the effects of buffer change on the refractive index of the SPR experiments.
Our results indicate that ORs display a binding capacity when prepared in NVs from yeast membranes. As 
shown, the curvature of the association part for OR17-40 in Fig. 5A is far from ideal which indicates rather 
complex association kinetics18. Furthermore, the association profile suggests a slow association rate constant (ka) 
between OR17-40 and helional. In OR7D4-NV, the association profile suggests a faster association rate constant 
(ka) because a steady state was reached within the same association time. In contrast, the sensorgram dissociation 
phase of odorants from both ORs-NVs did not show any curvature. This unexpected behavior was not the result 
of the double reference method used to analyze the data, but rather appeared to indicate a strong stability of the 
protein-ligand interaction in the NVs in vitro. This behavior differs from that found by Cook et al.19 in solubilized 
ORs, which displayed standard association and dissociation phases. Using artificially reconstituted liposomes, 
Oh et al.20 also observed a fast dissociation. Similarly, Lee et al.21 found a fast dissociation rate in experiments 
performed in human embryonic kidney (HEK)-293 cells expressing olfactory receptors. Hence, neither cellular 
machinery nor receptor environment appears to impact the OR-odorant ligand dissociation phase. However, the 
Figure 4. Number of receptors per NV (ORs/NV) as a function of NV concentration. The black dots 
correspond to c-myc-OR1740-NV and the grey dots correspond to c-myc-OR7D4-NV. The dark grey area 
shows (3 ± 1) c-myc-OR1740/NV and the light grey area shows (6 ± 2) c-myc-OR7D4/NV. Results from repeat 
experiments are shown with an asterisk (*).
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Figure 5. Optical images of the Biacore T100 flow cell. In the SPR assay, a solution of nanovesicles and 
control nanovesicles is immobilized in two different channels (A). Then, three helional solutions at different 
concentrations are sequentially flowed across the cell (B). A solution of nanovesicles and control nanovesicles 
is again immobilized in the two remaining channels (C) and control heptanal solutions sequentially flowed 
through the two channels (D).
Figure 6. (A) Double-reference SPR sensorgrams obtained by flowing solutions of helional at 2 µM (data in 
violet), 3 µM (data in green) and 5 µM (data in orange) onto a L1 chip with OR17-40-NV (flow rate: 60 µL/
min). The association phase was followed for 180 s and the dissociation phase was followed for 620 s. Inset: 
Corresponding sensorgrams obtained by flowing through the same chip heptanal solutions at the same 
concentrations. (B) Double-subtracted SPR sensorgrams obtained by flowing solutions of androstenone at 1 µM 
(data in violet), 5 µM (data in green) and 10 µM (data in orange) onto a L1 chip with OR7D4-NV (flow rate: 
60 µL/min).
Figure 7. SPR response of OR17-40-NV vs. helional concentration (data in blue) and of OR7D4-NV vs. 
androstenone concentration (data in red). The corresponding linear fits give: y = 1.82·x (blue line) and 
y = 0.55·x (red line).
www.nature.com/scientificreports/
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results obtained with SPR must be compared carefully, because a not accurate reference analysis could induce a 
reduction in the sensorgram signal when the odorant injection finishes.








Where Rmax is the maximum binding capacity (RU), Rl is the response level of immobilized ligands, Mwa is the 
molecular weight of analyte, Mwl is the Molecular weight of ligand and S is the number of binding sites per ligand.
Using this approach, the incremental SPR binding signal ratio obtained in presence of the highest odorant 
concentration is approximately 1/100 (10−2) (Supplementary Figure S5 and Fig. 6). Bearing in mind that the 
weight of each odorant molecule is around 10−10 pg. and the weight of each NV is around 10−4 pg. From Eq (1) 
our results would indicate that 10000 (10–2/10−6) odorant molecules might interact with each NV and hence, 
between 102 and 103 odorant molecules might interact with each OR. Even considering that the linearity of the 
equation is not conserved, it seems that we are far from a one-to-one interaction and many odorants interact with 
a nanovesicle and in consequence few odorants interact with an OR. The difficulties to understand completely 
the SPR sensorgram (association and dissociation phase) and the low level of SPR signal make it difficult to 
specify the value. This hypothesis would be consistent with the evidence that ORs recognize their cognate ligands 
through a network of distinct aminoacid residues disposed in their transmembrane domain, and that additional 
residues may be also involved in odorant interaction22,23.
Although the number of olfactory receptors in NVs was in the low range of a few ORs/NV, a fact that is con-
sistent with the general expression level of recombinant GPCR in cellular systems, NVs preparation together with 
a careful choice of SPR experimental conditions and data analysis, allowed us to clearly demonstrate the very 
good specificity of odorant ligand binding. Moreover, the study showed that the level of odorant binding onto 
ORs depends on odorant concentration in both receptors. A lowest detection limit of odorant binding to its OR 
was obtained, when compared to other groups19–21. The study confirms that ORs embedded in nanovesicles prop-
erly bind to their cognate odorants, which opens possibilities for their use as recognition biomaterial for odorant 
detection at low concentrations.
Methods
Chemicals and Material. Reagents. In this work, the reagents phosphate-buffered saline (PBS), anti-
mouse IgG peroxidase, Tween 20, tetramethylbenzidine (TMB), sodium citrate, 3-[(3-cholamidopropyl)
dimethylammonio]-1-propanesulfonate hydrate (CHAPS), dimethyl sulfoxide (DMSO), 4-(2-hydroxyeth-
yl)-1-piperazine-ethanesulfonic acid (HEPES), bovine serum albumin (BSA), triethylene glycol mono-11-mer-
captoundecyl ether (PEG3-thiol), androstenone, pentadecalactone, and heptanal were purchased from 
Sigma-Aldrich Chemie GmbH (Germany). Helional was a generous gift from Givaudan-Roure (Dübendorf, 
Switzerland), courtesy of B. Schilling. Potassium dihydrogen phosphate, disodium hydrogen phosphate, sodium 
carbonate, sodium hydrogen carbonate, and Tris (hydroxymethyl) aminomethane were purchased from Merck 
(Darmstadt, Germany). NaOH pellets, sodium chloride, and ethanol absolute were obtained from Panreac 
Química S.A.U. (Barcelona, Spain). The 2-(2-{2-[2-(2-[2-(11-mercapto-undecyloxy)-ethoxy]-ethoxy)-ethox-
y]-ethoxy}-ethoxy (SAM-COOH) was supplied by ProChimia Surfaces Sp. (Sopot, Poland). The FC14 detergent 
was acquired from Affymetrix Anatrace products (Santa Clara, USA). Nitrocellulose membranes (HybondTM-C 
extra) were from Amersham (GE Healthcare Europe). The monoclonal anti-c-myc IgG1 9E10 antibody and the 
antiproteases inhibitors cocktail were obtained from Roche Diagnostics (Mannheim, Germany). Profound TMc-
Myc Tag IP/Co-IP kit was supplied by Thermo Scientific (Rockford, IL, USA). In addition, MaxiSorp polysty-
rene 96-well plates were purchased from Nunc (Roskilde, Denmark). L1 sensor chips were purchased from GE 
Healthcare Bio-Sciences AB (Uppsala, Sweden). The gold chip for SPR measurements was purchased from GWC 
Technologies Inc.
Buffers and solutions. Buffers used were as follows: phosphate-buffered saline (PBS) 10 mM at pH 7.5, PBST as 
PBS with 0.05% Tween 20 and PBT as potassium dihydrogen phosphate/disodium hydrogen phosphate (10 mM at 
pH 7.5) with 0.05% Tween 20. The Tris buffer was at 1 M pH 8 and TBST was 25 mM tris-buffered saline (pH 7.2) 
Figure 8. Scheme representing the SPR signal obtained by the SPR based assay presented that uses double-
reference analysis.
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and 0.15 M NaCl with 0.05% Tween 20. Coating buffer was 50 mM carbonate/bicarbonate at pH 9.6. Citrate buffer 
was sodium citrate 40 mM solution at pH 5.5. The substrate solution was 0.01% TMB and 0.004% H2O2 in citrate 
buffer. The running buffer used in Biacore experiments was HBSN (25 mM HEPES, 150 mM sodium choride) 
with 1% dimethyl sulfoxide (DMSO) at pH 7.4. The CHAPS solution used was 20 mM at pH 7.4.
Equipment/Software. 2-D cryo-imaging was obtained using the FEI Tecnai microscope (FEI Company, 
Eindhoven, Netherlands). The peristaltic pump used was from Ismatec (Glattbrugg, Switzerland) and the 
Surface Plasmon Resonance RT2005 equipment was from Resonant Technologies GmbH (Germany). Proteins 
from the different yeast membrane fraction batches were quantified using the Pierce BCA Protein Assay kit 
(Thermo Scientific, USA) to obtain the Total Protein Concentration (TPC), and eluted c-myc-tagged OR, on a 
Nanodrop instrument (Labtech, UK). Protein bioconjugates were characterized by MALDI-TOF-MS (matrix 
assisted laser desorption ionization time-of-flight mass spectrometer) from Bruker Biflex III (Bruker, Karlsruhe, 
Germany). The washing steps in the ELISA assays were carried out using an ELx405 HT microplate washer 
(BioTek, Winooski, VT). The software packages used to read and analyze the ELISA results were SpectramaxPlus 
(Molecular Devices, Sunnyvale, CA) and GraphPad Prism v4.00 (GraphPad Software Inc., San Diego, CA). 
The olfactory receptor binding experiments were performed on a Biacore T100 instrument, GE Healthcare 
Bio-Sciences AB. All biosensor data processing and analysis was performed using Scrubber2 software (BioLogic 
Software). The AFM images were acquired with a MFP-3D AFM (Asylum Research) and analyzed using WSxM 
software (Nanotech, http://www.nanotec.es/).
Nanovesicles. Nanovesicles preparation. Human olfactory receptor c-myc-OR17–40 (ORL520 in OrDB), 
chimpanzee olfactory receptor c-myc-OR7D4, and somatostatin receptor subtype 2 (SSTR2) were expressed 
in different yeast Saccharomyces cerevisiae cultures. Membrane fractions were obtained following a procedure 
described in the literature11,24. Prior to use, the stock suspension of membrane fractions was diluted in the cor-
responding phosphate buffer according to the corresponding method. Further homogenization steps, as well as 
the characterization of the NVs (size, concentration, etc.), were performed following the protocol described in 
previous works10,25. ELISA assays: The stock suspension of the membrane fractions was diluted in PBT at a total 
protein concentration (TPC) of 60 μg/mL. Subsequently, more PBT buffer was added to this solution until work-
ing NV concentrations were reached. Surface immobilization assays: Membrane fractions were diluted in PBS at a 
total protein concentration between 60–85 μg/mL. Biacore T100 assays: NV solutions were prepared in PBS at the 
total protein working concentration of 15 µg/mL following the same protocol.
Cryo-electron microscopy (Cryo-EM). The two-dimensional (2D) imaging of vitrified NV samples was per-
formed on a FEI Tecnai electron microscope (cryo-EM) operating at 200 kV, at a temperature between minus 
170 °C and minus 175 °C under low-dose imaging conditions.
Nanovesicles immobilization onto a carboxylic functionalized self-assembled monolayer (SAM-COOH) on gold sur-
face. The SAM over the gold SPR sensor chip was formed by immersing the cleaned SPR sensor chip into the 
2 mM thiol solution SAM-COOH for 16–20 hours. The unbound thiols were removed by rinsing with absolute 
ethanol and the substrate dried under nitrogen for subsequent use. The chip was index-matched to a prism and 
fitted with a 20 μL flow cell connected to a peristaltic pump. NVs immobilization was performed using a solution 
of 5.59·1010 NV/mL (85 μg/mL TPC) at a flow speed of 58 μL/min. The interaction of NVs with the functionalized 
gold substrates was followed by Surface Plasmon Resonance (Supplementary Information, S1). At the end of the 
experiment, AFM images were taken to evaluate NVs morphology on the surface.
AFM measurements. The AFM images were acquired with a MFP-3D AFM (Asylum Research) in tapping mode 
in liquid, using Si3N4 tips coated with Au/Cr with a spring constant of 0.08 N m−1 (Olympus cantilevers) at a scan 
rate of 1 Hz.
c-myc-OR Protein Quantification after solubilization. Proteins solubilization. Fos-choline-14 
(FC14) detergent was used for efficient solubilization of ORs, as described by Cook et al.19 To investigate the crit-
ical step of solubilization, a range of detergent concentrations relative to its critical micelle concentration (CMC) 
were tested for two different concentrations: 10 to 350 CMC, both with the same amount of membrane fraction. 
Then, the samples were dot blotted onto a nitrocellulose membrane and hybridized with a commercial anti-c-myc 
mAb. The minimal efficient FC14 concentration (50 CMC) was determined though correlation analysis between 
the diameter of the dots and the level of solubilization (data not shown). Solubilization of c-myc-OR17–40 and 
c-myc-OR7D4 from 450 μg of membrane fractions was performed using FC14 detergent (50 or 350 CMC) 
together with an antiprotease inhibitor cocktail at 4 °C for 3 hours with gentle end-over-end mixing.
Olfactory receptor protein quantification. The quantification of solubilized cmyc-ORs was performed using the 
ProfoundTMc-Myc Tag IP/Co-IP kit. 10 µL of anti c-myc-agarose was delivered into the solubilized c-myc-ORs 
in spin columns. The incubation was done with gentle end-over-end mixing at 4 °C overnight. To ensure that 
contaminating proteins were discarded, the number of necessary washes was determined by measuring the pro-
tein concentration after each wash. After eight washes with 0.5 mL TBST, the c-myc-tagged proteins were eluted 
with 4 × 10 μl elution buffer. The eluates were neutralized with 2 μl of Tris buffer pH 9. Proteins were quantified 
by Nanodrop at 280 nm, by performing 10 measurements on each eluate. Each eluate was analyzed using western 
blotting with anti-c-myc antibodies (20 μl of eluate, commercial anti-c-myc antibody 1:8000).
c-myc-OR Quantification per nanovesicle. The method we developed to directly quantify the number 
of receptors per NV is based on an indirect competitive ELISA immunoassay that is performed on the NV sample 
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(see Materials and Methods). The major benefit of this method is that the quantification of olfactory receptor 
expression can be performed directly without the need of previous solubilization and purification of the olfactory 
receptors from their natural lipid environment.
These assays were performed following a novel immunochemical strategy. The specificities of the methodol-
ogy from a biochemical point of view (description of competitive ELISA assay optimization, design of the anti-
gen/antibody structure, matrix characteristics, physico-chemical buffer conditions, choice of the bioconjugates, 
optimal working concentrations, choice of the mathematical model for the data analysis) were published in a 
recent study26.
Competitive indirect ELISA. Calibration curves in competitive assays were obtained using four different 
c-myc-bioconjugates (well-known proteins conjugated with the c-myc peptide and well characterized by 
MALDI-TOF-MS [data not shown]). Three of these were synthesized to be used as analytes and one as coating 
antigen. First, 96-well plates were coated with the antigen (0.0125 μg/mL in coating buffer) and left at room 
temperature for four hours. Next, the plates were washed with PBST. All the washing steps consisted of filling up 
the wells with PBST (300 μL) and immediately aspirating the solutions using a vacuum pump with an automated 
microplate washer, on four cycles. The analyte solution, i.e., the c-myc-OR-NV solutions (25–45 μg mL−1 TPC 
in PBT) or the c-myc-bioconjugates (200–0.008 nM in presence of SSTR2 nanovesicles) were added. This was 
followed by the addition of custom-made anti-c-myc monoclonal antibodies (1:160000). Next, the plates were 
washed again with PBST and the commercial antibody anti-IgG-HRP (1:6000) was incubated. The plates were 
then washed again with PBST and the substrate solution was added and incubated before the enzymatic reaction 
was stopped and the absorbances measured at 450 nm (see Fig. 3).
The curves obtained were fitted following a typical four-parameter logistic equation27. Using competitive 
assays, we carried out the c-myc-OR17-40 and c-myc-OR7D4 quantification per NV at different NV concen-
trations, for c-myc-OR17-40 at 7.0·1010–12.6·1010 NV/mL with 25–45 μg/mL of TPC, and for c-myc-OR7D4 at 
4.2·1010–7.5·1010 NV/mL with 25–45 μg/mL of TPC (Supplementary Information, S2). The absorbance values of 
c-myc-OR samples were interpolated in each corresponding c-myc-bioconjugate calibration curve at the same 
concentration to obtain the concentration of the c-myc tag in solution which is proportional to the number of 
c-myc-ORs. The data presented correspond to the average of three well replicates. The assay reproducibility was 
also evaluated for c-myc-OR17-40 (n = 6) and for c-myc-OR7D4 (n = 4).
Olfactory Receptor binding functionality. Studies were performed at 25 °C using Biacore T100 and 
L1 sensor chips preconditioned with three pulses of CHAPS for 1 min each at 5 μl/min and three pulses of 
Isopropanol:NaOH 50 mM (2:3) for 1 min each at 5 μl/min. All solutions were filtered through 0.22 μm porous 
filter before use.
Odorant solubilization. Odorant solutions were prepared in a fume hood. An initial stock solution of either heli-
onal or heptanal at 10−1 M in DMSO was prepared and then used to prepare the odorant working concentrations 
(1, 2, 3, 5, or 10 µM) maintaining a constant concentration of 1% of DMSO. For androstenone and pentadecalac-
tone, we prepared a stock solution at 10−2 M in DMSO which was used to produce odorant working concentra-
tions of 1, 5, and 10 µM while again maintaining exactly 1% of DMSO. The blank solutions were prepared in the 
exact same way as the odorant solution, but replacing the odorant with DMSO.
Nanovesicles capture. NVs were immobilized on the surface of a L1 Biacore chip whose matrix contained lipo-
philic groups covalently attached to carboxymethylated dextran. This sensor chip was chosen for its high capacity 
for direct attachment of lipid vesicles and its stability over time. Since the lipid bilayer structure is retained after 
attachment, we can study interactions involving transmembrane receptors in a native-like environment. NVs 
were injected onto L1 sensor chips at 5 µL/min for 30 minutes to achieve capture levels of about 1200 resonance 
units (RU). A short pulse (1–3 minutes) of 5 mM NaOH was injected onto the deposited nanovesicles to get rid 
of potential multilayers. BSA (0.1 mg/mL in PBS) was then flowed at 5 µL/min for 5 minutes to block the sensor 
chip surface from unspecific odorant adsorption (Supplementary Information, S3). Odorant binding assessment 
at different concentrations was performed on a non-regenerated NV surface.
Odorant analysis. At first, the chip was initialized with running buffer solution (HBSN with 1% DMSO) for chip 
stabilization. Then, different concentrations (1, 2, 3, 5 or 10 µM) of odorants were injected (in order of increasing 
concentrations either onto the same channel or as separate injections onto different channels) over a period of 
3 minutes at a flow rate of 60 µL/min.
Data processing and analysis. We followed a double reference system to analyze the responses28 based on two 
control channels: for the c-myc-OR17–40 a channel functionalized with SSTR2-NVs (reference channel) was 
used, and either helional or heptanal (control odorant) or buffer (blank) were used. Signals from the SSTR2 
reference with either odorant or buffer were subtracted from the corresponding signals of the c-myc-OR17-40 
channel. For the c-myc-OR7D4 channel a similar procedure was used, with c-myc-OR1740 as the reference, 
androstenone as odorant, and pentadecalactone as control odorant. The limit of detection (LOD) was estimated 
to equal the concentration corresponding to the signal of the blank, i.e., that coming from flowing the running 
buffer through the captured NVs, plus three times its standard deviation. The assay sensitivity was determined 
as the slope of the linear fit through a plot of RU vs. odorant concentration, in μM. We performed a total of 
seven experiments for each odorant concentration (OR17-40-NV vs. helional, control NV: SSTR2-NV), four 
experiments (OR17-40-NV vs. helional, control NV: OR7D4-NV) and twenty experiments (OR7D4-NV vs. 
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androstenone, control NV: OR17-40-NV). The percentage of experiments that gave a response towards the cor-
responding odorant was 76%, 75% and 35%, respectively, due to the difficulty in preparing the samples and the 
small signal difference to be observed between the sample channel and the reference channel.
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